Get the Stockscreener App
1.61
0.63%
0.01
After Hours:
1.61
Biorestorative Therapies Inc stock is traded at $1.61, with a volume of 27,291.
It is up +0.63% in the last 24 hours and up +4.55% over the past month.
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
See More
Previous Close:
$1.60
Open:
$1.61
24h Volume:
27,291
Relative Volume:
0.34
Market Cap:
$12.84M
Revenue:
$149.50K
Net Income/Loss:
$-6.96M
P/E Ratio:
-1.1838
EPS:
-1.36
Net Cash Flow:
$-6.37M
1W Performance:
-0.62%
1M Performance:
+4.55%
6M Performance:
-9.55%
1Y Performance:
-4.73%
1-Day Range:
$1.5609
$1.62
1-Week Range:
$1.555
$1.73
52-Week Range:
$1.19
$2.55
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Name
Biorestorative Therapies Inc
Sector
Industry
Phone
(631) 760-8100
Address
40 MARCUS DRIVE, MELVILLE
Compare BRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
1.61 | 12.76M | 149.50K | -6.96M | -6.37M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Biorestorative Therapies Inc Stock (BRTX) Latest News
Price momentum metrics for BioRestorative Therapies Inc. explainedPortfolio Value Summary & Stepwise Swing Trade Plans - newser.com
Will BioRestorative Therapies Inc. stock return to pre crisis levelsOil Prices & Daily Momentum Trading Reports - newser.com
D pipelineJuly 2025 Recap & Daily Price Action Insights - newser.com
Chart based analysis of BioRestorative Therapies Inc. trendsJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com
Is BioRestorative Therapies Inc. (9OF) stock a defensive play amid uncertaintyTrade Risk Summary & Technical Pattern Alert System - newser.com
Published on: 2025-10-13 08:28:27 - newser.com
Can BioRestorative Therapies Inc. (9OF) stock deliver strong annual returnsPortfolio Gains Summary & Daily Chart Pattern Signals - newser.com
Live market analysis of BioRestorative Therapies Inc.Portfolio Gains Summary & Technical Pattern Alert System - newser.com
How to interpret RSI for BioRestorative Therapies Inc. stockBuy Signal & Comprehensive Market Scan Insights - newser.com
Published on: 2025-10-13 04:10:23 - newser.com
BioRestorative Therapies Inc 9OF Stock Analysis and ForecastEarnings Surprise Analysis & High Profit Market Tips - earlytimes.in
BioRestorative Therapies Inc. stock daily chart insights2025 Pullback Review & Advanced Technical Analysis Signals - newser.com
Can volume confirm reversal in BioRestorative Therapies Inc.2025 Market Outlook & AI Driven Stock Movement Reports - newser.com
BioRestorative Therapies, Inc. announced that it has received $1.398628 million in funding - MarketScreener
Published on: 2025-10-09 00:29:38 - newser.com
BioRestorative Therapies Announces Direct Offering Agreement - TipRanks
What drives BioRestorative Therapies Inc stock priceStock Split Announcements & In-Depth Analyst Ratings Explained Simply - earlytimes.in
BioRestorative CEO Lance Alstodt Interviewed on “The Big Biz Show” - GlobeNewswire
Airs in 175 countries: BioRestorative CEO Lance Alstodt on Emmy-winning The Big Biz Show via Roku, iHeart - Stock Titan
BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market - GlobeNewswire
BioRestorative Therapies raises $1.085 million in registered offering By Investing.com - Investing.com Nigeria
BioRestorative Therapies, Inc. (BRTX) Stock: Rebounds Strongly as $1.085M Direct Offering Boosts Investor Confidence - CoinCentral
BioRestorative Therapies raises $1.085 million in registered offering - Investing.com India
BioRestorative Therapies stock falls after $1.1M registered offering - Investing.com
BioRestorative Therapies, Inc. Secures $1.085 Million in Direct Offering and Private Placement - Quiver Quantitative
$1.085M raise: BioRestorative sells 678,125 shares at $1.60 with 508,594 warrants (75%) - Stock Titan
Does BioRestorative Therapies Inc. stock trade at a discount to peersMarket Activity Report & Technical Confirmation Trade Alerts - newser.com
How supply chain issues affect BioRestorative Therapies Inc. stockOil Prices & Fast Exit/Entry Strategy Plans - newser.com
BioRestorative Therapies Inc Stock Analysis and ForecastDividend Yield Trends & Stay One Step Ahead of Risk Events - earlytimes.in
Why BioRestorative Therapies Inc. (9OF) stock stays on top picksEarnings Growth Summary & Verified Short-Term Plans - newser.com
What to expect from BioRestorative Therapies Inc. in the next 30 daysTake Profit & Growth Oriented Trade Recommendations - newser.com
Can you recover from losses in BioRestorative Therapies Inc.July 2025 Sector Moves & Safe Entry Point Alerts - newser.com
Chart based exit strategy for BioRestorative Therapies Inc.2025 Short Interest & Fast Gaining Stock Reports - newser.com
How hedge fund analytics apply to BioRestorative Therapies Inc. stockJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - newser.com
Is BioRestorative Therapies Inc. stock a top momentum playMarket Volume Report & Low Drawdown Momentum Trade Ideas - newser.com
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Down 1.4%Here's Why - MarketBeat
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Down 1.4% – Here’s Why - Defense World
Biorestorative Therapies Inc Stock (BRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):